Companies: 10,795·Total market cap: $144.5T

Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd.

KMTSNASDAQHealthcare● Active

$19.74

+$0.34(+1.75%)

Market Cap$1.2B

P/E Ratio—

52W High$30

52W Low$13.25

Avg Volume358K

Open$19.59

Beta0.83

Net Income Financials Revenue

Kestra Medical Technologies, Ltd. (KMTS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

KMTS · net income · updated Jun 9, 2026

Core profitability metrics

KMTS · net income · margin · TTM · CAGR

Net income was −$113.8M for FY2025 (fiscal year ending 2025-04-30), down 20.9% year-over-year. Net profit margin was -190.3%.

FY2025 Net Income−$113.8M▼ -20.9% YoY

Trailing 12M (TTM)−$144.8Mtrailing 4 quarters sum

Net Profit Margin-190.3%−$113.8M ÷ $59.8M

YoY Change-20.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · KMTS net income history · KMTS profit margin

Annual net income data

KMTS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$113.8M▼ 20.9%-190.3%$59.8M

FY2024Loss−$94.1M▼ 11.7%-338.4%$27.8M

FY2023Loss−$84.2M▼ 147.0%-1104.0%$7.6M

FY2021Loss−$34.1M▼ 15.7%—$0

FY2020Loss−$29.5M——$0

Net income vs peers (Healthcare)

KMTS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Kestra Medical Technologies, Ltd.YOU

KMTS

−$113.8M-20.9%-190.3%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Kestra Medical Technologies, Ltd. (KMTS) reported net income of −$113.8M for FY2025 (fiscal year ending 2025-04-30), down 20.9% year-over-year. The net profit margin was -190.3% — meaning the company kept $-1.90 of every dollar of revenue as profit.

Kestra Medical Technologies, Ltd. has not yet achieved annual profitability based on available data (5 fiscal years). The company has reported net losses across all available periods.

Kestra Medical Technologies, Ltd.'s net profit margin was -190.3% for FY2025, based on the latest annual results.

Investors sometimes search for "Kestra Medical Technologies, Ltd. net worth" — the company's market capitalization is a separate figure from KMTS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

KMTS net income · 4 questions

Kestra Medical Technologies, Ltd. is not currently profitable on an annual basis. The company reported a net loss of $113.8M for FY2025.

is KMTS profitabledoes KMTS make a profitKMTS profitabilityKMTS profitable company

▸ Source: FMP /income-statement · GAAP · Kestra Medical Technologies, Ltd. · Kestra Medical Technologies, Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026